biopharmaceuticals

CPHI Middle East opens in 2024 for the expanding regional pharma manufacturing base

Riyadh, October 03, 2023 :  A new event for global pharma will launch in 2024 with CPHI Middle East opening at the…

1 year ago

PFIZER RANKED AS LEADING COMPANY IN ASIA FOR COVID-19 RESPONSE AND PATIENT-CENTRIC APPROACH BY ASIAN PATIENT GROUPS

  SINGAPORE, AUGUST 29, 2022:  Pfizer is ranked 1st in Australia/New Zealand region and overall 2nd in Asia in its corporate reputation…

2 years ago

CPhI Worldwide 2019 Annual Pharma Industry Report – German data

German pharma benefiting from a Brexit boost? Germany consolidates itself as world leader in pharma according to the CPhI Pharma…

5 years ago

Drive for generics sees Korea increasingly attractive to international pharma

CPhI Korea data shows an increase in 'overall competitiveness' Amsterdam, July 31, 2019: Already home to more than 40 pharmaceutical…

5 years ago

U.S. FDA Approves Mylan and Biocon’s Fulphila™ (pegfilgrastim-jmdb), the First Biosimilar to Neulasta®

Fulphila is expected to be the first biosimilar pegfilgrastim available in the U.S. to help patients with nonmyeloid cancers reduce…

6 years ago

Signing of Legal Agreements between Govt. of India and World Bank on National Biopharma Mission

New Delhi, April 27, 2018: Towards strengthening the emerging biotechnology enterprise in India, Department of Biotechnology (DBT), Ministry of Science…

7 years ago

Pricing system reform and generics trend apparent at CPhI Japan 2018

Bio and generic demand reflective of wider trends in the market – with overseas investments now prospering Amsterdam, March 21,…

7 years ago